| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/AJG.2014.300 |
| P698 | PubMed publication ID | 25350768 |
| P50 | author | Gilaad G. Kaplan | Q38544138 |
| Herman W. Barkema | Q40632634 | ||
| Subrata Ghosh | Q59832001 | ||
| Remo Panaccione | Q92078930 | ||
| P2093 | author name string | Fiona Clement | |
| Steven J Heitman | |||
| Stephanie Coward | |||
| Cynthia Seow | |||
| Maria Negron | |||
| Yvette P Y Leung | |||
| P2860 | cites work | High smoking cessation rate in Crohn's disease patients after physician advice--the TABACROHN Study. | Q44045092 |
| Smoking cessation and the course of Crohn's disease: an intervention study | Q44196700 | ||
| The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. | Q46237474 | ||
| Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial | Q46310193 | ||
| Assessment of variables associated with smoking cessation in Crohn's disease | Q48011015 | ||
| Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. | Q50795640 | ||
| Direct medical cost of managing IBD patients: a Canadian population-based study. | Q50991301 | ||
| Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study. | Q53079724 | ||
| Smoking cessation among self-quitters | Q60725749 | ||
| The cost of hospitalization in Crohn's disease | Q73471336 | ||
| Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease | Q75414705 | ||
| An evaluation of utility measurement in Crohn's disease | Q85829386 | ||
| Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review | Q22250934 | ||
| Nicotine receptor partial agonists for smoking cessation | Q24200322 | ||
| Pharmacological interventions for smoking cessation: an overview and network meta-analysis | Q24202961 | ||
| Nicotine replacement therapy for smoking cessation | Q24202991 | ||
| Individual behavioural counselling for smoking cessation | Q24244057 | ||
| A meta-analysis of the role of smoking in inflammatory bowel disease | Q28262131 | ||
| Defining quality indicators for best-practice management of inflammatory bowel disease in Canada | Q33725615 | ||
| Environmental risk factors for inflammatory bowel disease | Q33916393 | ||
| The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? | Q34147687 | ||
| Varenicline, smoking cessation, and neuropsychiatric adverse events | Q34546833 | ||
| Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial | Q34574245 | ||
| Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies | Q34609514 | ||
| Risk of early surgery for Crohn's disease: implications for early treatment strategies | Q35612431 | ||
| Inflammatory bowel disease: a Canadian burden of illness review | Q36391797 | ||
| Environment and the inflammatory bowel diseases | Q37066404 | ||
| Does smoking reduce infliximab's effectiveness against Crohn's disease? | Q37223014 | ||
| Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review. | Q37378998 | ||
| Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab. | Q37579956 | ||
| Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review | Q37853354 | ||
| Cost per treated patient for etanercept, adalimumab, and infliximab across adult indications: a claims analysis | Q37992954 | ||
| Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies | Q38125012 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Crohn's disease | Q1472 |
| P304 | page(s) | 368-377 | |
| P577 | publication date | 2014-10-28 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Funding a smoking cessation program for Crohn's disease: an economic evaluation | |
| P478 | volume | 110 |
| Q90339285 | British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults |
| Q33621700 | Healthcare maintenance in elderly patients with inflammatory bowel disease |
| Q40013690 | Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study |
| Q52816498 | Letter: deleterious effects of smoking on post-operative Crohn's disease - authors' reply. |
| Q92896776 | Modifiable risk factors for poor health outcomes in multiple sclerosis: The urgent need for research to maximise smoking cessation success |
| Q36237284 | Satisfaction and expectations of patients with inflammatory bowel disease on biologic therapy: a multicenter study |
| Q43760050 | Smoking Cessation for Crohn's Disease: Clearing the Haze |
| Q41655711 | Smoking Cessation in a Chronic Pancreatitis Population |
| Q36088359 | Smoking Is Associated with an Increased Risk for Surgery in Diverticulitis: A Case Control Study |
| Q47656552 | Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease |
| Q38691469 | Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease. |
| Q36864731 | The Association of Smoking and Surgery in Inflammatory Bowel Disease is Modified by Age at Diagnosis |
| Q52815050 | The Importance of Smoking Cessation in Improving Disease Course in Crohn's Disease. |
| Q38577572 | The global burden of IBD: from 2015 to 2025. |
Search more.